Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.01% Nasdaq Down 0.04%
Streaming
Ticker Tape: On

Synageva BioPharma Corp. (GEVA)

-NasdaqGS

40.55 Up 0.26(0.65%) 3:54PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:40.29
Open:40.03
Bid:40.46 x 200
Ask:40.59 x 100
1y Target Est:59.43
Beta:0.73
Next Earnings Date:29-Jul-13GEVA Earnings announcement
Day's Range:39.82 - 40.72
52wk Range:34.01 - 58.00
Volume:62,214
Avg Vol (3m):97,142
Market Cap:1.11B
P/E (ttm):N/A
EPS (ttm):-2.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GEVA

Comparison

Symbol% ChgMkt Cap
GEVAUp 0.65%1.11B
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.97%11.77B
SUNPHARMA.NSUp 0.41%1.04T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):62.16
Ex-Dividend Date:30-Dec-08

Analysts

Annual EPS Est (Dec-13) :-3.25
Quarterly EPS Est (Jun-13) :-0.78
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synageva BioPharma Corp., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback